Cardiac Biotech Solutions (CBSC) Stock Price, News & Analysis

Company Overview

CB Scientific, Inc., through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.04 to $0.04
• 52-Week Range: $0.02 to $0.15
• Volume: 1,200 shs
• Average Volume: 57,096 shs
• Market Capitalization: $6.62 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CBSC Stock Analysis - Frequently Asked Questions

How have CBSC shares performed this year?

Cardiac Biotech Solutions' stock was trading at $0.0650 at the beginning of 2025. Since then, CBSC stock has decreased by 38.5% and is now trading at $0.04.

How do I buy shares of Cardiac Biotech Solutions?

Shares of CBSC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cardiac Biotech Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiac Biotech Solutions investors own include BlackRock MuniHoldings California Quality Fund (MUC), Tilray Brands (TLRY), TE Connectivity (TEL), Smith & Wesson Brands (SWBI), Houghton Mifflin Harcourt (HMHC) and Global Wholehealth Partners (GWHP).

Company Calendar

• Today: 9/12/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:CBSC
• CIK: N/A
• Web: cbscientificinc.com
• Phone: (888) 225-0870
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $140 thousand
• Price / Sales: 47.27
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 165,439,000
• Free Float: N/A
• Market Cap: $6.62 million
• Optionable: Not Optionable
• Beta: 1.14